Crosstalk between iron metabolic disorder and lipid metabolic disorder in hepatocarcinogenesis
Crosstalk between iron metabolic disorder and lipid metabolic disorder in hepatocarcinogenesis
批准号:
20590782
负责人:
HINO Keisuke
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010
中文摘要
代谢紊乱,如铁超载和/或肝脏脂肪沉积,是丙型肝炎病毒(HCV)相关肝癌发生的众所周知的病理生理学特征之一。利用表达丙型肝炎病毒多聚蛋白的雄性转基因小鼠,在肝脏铁超载的情况下发生肝脏脂肪变性继而发生肝细胞癌,研究了肝脏铁超载促进肝脏脂肪变性发生的机制。肝铁水平与肝脏中甘油三酯浓度呈正相关。铁相关的氧化应激加重线粒体损伤,导致肉碱棕榈酰转移酶I的表达减少,并诱导未折叠蛋白反应,从而增加参与脂质合成的转录因子--固醇调节元件结合蛋白I的表达。
英文摘要
Metabolic disorders such as iron overload and/or fatty deposition in the liver are one of the well-known pathophysiological features in hepatitis C virus (HCV)-associated hepatocarcinogenesis. Using male transgenic mice expressing the HCV polyprotein which develop hepatic steatosis followed by hepatocellular carcinoma in the presence of hepatic iron overload, we investigated the mechanisms by which hepatic iron overload contributed to the development of hepatic steatosis. Hepatic iron levels were positively correlated with triglyceride concentrations in the liver. Iron-related oxidative stress aggravated mitochondrial injury leading to reduced expression of carnitine palmitoyl transferase I, and induced unfolded protein response which in turn increased the expression of sterol-regulatory element binding protein I, a transcription factor involved in lipid synthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Recommendation of Lamivudine-to-Entecavir switching treatment in chronic hepatitis B responders : Randomized controlled trial
慢性乙型肝炎反应者拉米夫定改为恩替卡韦转换治疗的建议:随机对照试验
DOI:
--
发表时间:
2011
期刊:
Hepatol Res
影响因子:
4.2
作者:
[Onoue M, Nishimura T(7番目), 他全12名, Tanaka Y]
通讯作者:
Tanaka Y
Effects of a late evening snack combined with alpha-glucosidase inhibitor on liver cirrhosis.
深夜零食联合α-葡萄糖苷酶抑制剂对肝硬化的影响。
DOI:
--
发表时间:
2008
期刊:
Hepatology Research 38(11)
影响因子:
--
作者:
[Korenaga K, Korenaga M]
通讯作者:
Korenaga M
Iron overload causes hepatic steatosis through the endopasmic reticulum stress in transgenic mice expressing the hepatitis C virus polyprotein.
在表达丙型肝炎病毒多蛋白的转基因小鼠中,铁超载通过内质网应激导致肝脂肪变性。
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[Nishina S, Hino K, Korenaga M, et al]
通讯作者:
et al
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
IL28B 与聚乙二醇干扰素-α 和利巴韦林治疗慢性丙型肝炎的反应的全基因组关联
DOI:
--
发表时间:
2009
期刊:
Nat. Genet. 41
影响因子:
--
作者:
[Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, S]
通讯作者:
S
DOI:
10.1111/j.1478-3231.2011.02469.x
发表时间:
2011-04-01
期刊:
LIVER INTERNATIONAL
影响因子:
6.7
作者:
[Korenaga, Masaaki, Hidaka, Isao, Hino, Keisuke]
通讯作者:
Hino, Keisuke
共 27 条
Restoration of mitophagy as a strategy for inhibiting hepatocarcinogenesis
-
批准号:25670374
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2013
-
负责人:HINO Keisuke
-
依托单位:
Analysis of hepatocarcinogenesis based on gender and mitochondrial biogenesis
-
批准号:23390201
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.15万
-
财政年份:2011
-
负责人:HINO Keisuke
-
依托单位:
Iron metabolic disorder and hepatocarcinogenesis in hepatitis C
-
批准号:18590736
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.51万
-
财政年份:2006
-
负责人:HINO Keisuke
-
依托单位:
Oxidative stress and hepatocarcinogenesis in hepatitis C
-
批准号:15590653
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:HINO Keisuke
-
依托单位:
海外基金